Fat Mass and Obesity-associated Gene Expression and Disease Severity in Type 2 Diabetes Mellitus
Overview
Affiliations
Patients And Methods: One hundred T2DM patients were divided into two equal groups according to diabetes control and complications and fifty healthy controls were included in this study. FTO messenger ribonucleic acid (mRNA) expression level was analyzed by Real time polymerase chain reaction (PCR) technique and serum level of FTO protein was measured by ELISA.
Results: FTO gene expression and FTO protein levels were increased in the two T2DM groups compared to the control group with significant further increases in patients with severe disease. FTO gene expression and FTO protein levels were positively correlated with obesity, insulin resistance and blood glucose indices as well as the presence of diabetic complications. Regression analyses showed that FTO gene expression and FTO protein levels were risk factors for T2DM severity.
Conclusions: Increased FTO gene expression and its serum protein levels are associated with increased T2DM severity.
Benak D, Sevcikova A, Holzerova K, Hlavackova M Front Cell Dev Biol. 2025; 12:1500394.
PMID: 39744011 PMC: 11688314. DOI: 10.3389/fcell.2024.1500394.
Gut microbiome: New perspectives for type 2 diabetes prevention and treatment.
Li S, Guo Y World J Clin Cases. 2023; 11(31):7508-7520.
PMID: 38078135 PMC: 10698456. DOI: 10.12998/wjcc.v11.i31.7508.
Zhou J, Zhu Y, Ai D, Zhou M, Li H, Li G J Transl Med. 2023; 21(1):781.
PMID: 37925419 PMC: 10625275. DOI: 10.1186/s12967-023-04630-5.
The role of mA and mAm RNA modifications in the pathogenesis of diabetes mellitus.
Benak D, Benakova S, Plecita-Hlavata L, Hlavackova M Front Endocrinol (Lausanne). 2023; 14:1223583.
PMID: 37484960 PMC: 10360938. DOI: 10.3389/fendo.2023.1223583.
Wassie T, Cheng B, Zhou T, Gao L, Lu Z, Xie C Front Immunol. 2022; 13:996897.
PMID: 36311785 PMC: 9614668. DOI: 10.3389/fimmu.2022.996897.